നാറ്റ്സ്മാർട്ടിന് എന്താണ് കുഴപ്പം? അനാവശ്യ വിവാദത്തിന് പിന്നിലെന്ത്? ആരോപണങ്ങൾ ബൂമറാങ്ങായോ? രോഗം വെച്ച് വേണോ രാഷ്ട്രീയക്കളി? വിവാദത്തിന് മരുന്നുണ്ടോ? സൂപ്പർ പ്രൈം ടൈം ചർച്ച
Content Highlights: SMA medicine controversy Kerala, Natco generic drug NatSmart, Health Minister K Muraleedharan, Risdiplam generic alternative Kerala, SMA treatment Kerala debate, Clinical trial labelling row, Spinal Muscular Atrophy Kerala, Kerala Health Department news, Super Prime Time discussion, Kerala politics SMA medicine, SMA medicine row Kerala, Spinal Muscular Atrophy treatment, Natco Pharma NatSmart generic, Super Prime Time Mathrubhumi News, Jerin Johnson MIND trust, Kerala health department SMA controversy, Muscular Dystrophy rehabilitation Oridam, K Muraleedharan health minister, physician sample clinical trial Kerala, rare disease treatment Kerala
Published: 23 Oct 2026, 09:35 pm IST
Related Topics
SMA medicine controversy Kerala
Natco generic drug NatSmart
Health Minister K Muraleedharan
Risdiplam generic alternative Kerala
SMA treatment Kerala debate
Clinical trial labelling row
Spinal Muscular Atrophy Kerala
Kerala Health Department news
Super Prime Time discussion
Kerala politics SMA medicine
SMA medicine row Kerala
Spinal Muscular Atrophy treatment
Natco Pharma NatSmart generic
Super Prime Time Mathrubhumi News
Jerin Johnson MIND trust
Kerala health department SMA controversy
Muscular Dystrophy rehabilitation Oridam
K Muraleedharan health minister
physician sample clinical trial Kerala
rare disease treatment Kerala
Get Latest Mathrubhumi Updates in English
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.

